Affimed Provides Follow-up Data of AFM24 plus Atezolizumab

In 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved 4...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Mannheim ,Baden Wüberg ,Germany ,Ukraine ,Russia ,Texas ,United States ,Hye Ryun Kim ,Mary Beth Sandin ,Andreas Harstrick ,Alexander Fudukidis ,Artiva Allo ,University Of Texas Md Anderson Cancer Center ,Professor At Yonsei University College Of Medicine ,Chief Medical ,Chief Executive Officer ,Yonsei University College ,Cancer Center ,